Fundraising Fox

Biscayne Pharmaceuticals

Miami, US · Founded 2012 · Florida corporation

Biotech

Founders & leadership

SD
Stephen D. CollinsExecutive
SJ
Samuel J. ReichExecutive
PG
Peter GoldsteinDirector of Research and Development
NL
Nair LaxmiDirector of Manufacturing and Development
JM
Jared MendelDirector of Finance and Operations

Board

WL
Warren LammertBoard director
JL
Jack LevineBoard director
NB
Norman BlockBoard director

Reported raises · per SEC filings

Form D private placements

$3.2M disclosed across 2 rounds · 2014–2015

▶$609KraisedNov 2015 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen D. CollinsExecutive Officer
  • Jack LevineDirector
  • Samuel J. ReichExecutive Officer, Director
  • Norman BlockDirector
  • Warren LammertDirector
Offering amount
$2M
Amount sold
$609K
First sale
Oct 2015
Incorporated
Corporation, Florida, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.6MraisedMay 2014 · 23 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter GoldsteinExecutive Officer
  • Samuel J. ReichExecutive Officer, Director
  • Nair LaxmiExecutive Officer
  • Jared MendelExecutive Officer
  • Norman BlockDirector
  • Jack LevineDirector
Offering amount
$6M
Amount sold
$2.6M
First sale
Apr 2014
Incorporated
Corporation, Florida, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Supernus to Acquire Biscayne Neurotherapeutics, Adding Epilepsy Candidategenengnews.com · Sep 2018Biscayne Neurotherapeutics Raises $3M for Chinese Medicine-Derived Antiepilepticgenengnews.com · Jan 2017Biscayne Announces Formation of Biscayne Neurotherapeutics and Completion of Series B Financingprnewswire.com · Jan 2017Miami-based Biscayne Neurotherapeutics receives $3 million in funding for developing anti-epileptic drug | Miami Heraldmiamiherald.com · Jan 2017Biscayne Pharma Forms Biscayne Neurotherapeutics and Completes $3 Million Series B Funding Round - BioSpacebiospace.com · Jan 2017Biscayne Pharmaceuticals closes $3.4 million funding round - South Florida Business Journalbizjournals.com · Jan 2015

Frequently asked questions

How much funding has Biscayne Pharmaceuticals raised?
Biscayne Pharmaceuticals has disclosed $3.2M raised across 2 rounds.
Where is Biscayne Pharmaceuticals headquartered?
Biscayne Pharmaceuticals is headquartered in Miami, US.